{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:03:11Z","timestamp":1792699391038,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03375-4","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T18:58:00Z","timestamp":1734116280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of Pseudomonas aeruginosa keratitis at Ho Chi Minh eye hospital"],"prefix":"10.1007","volume":"45","author":[{"given":"Phuc Huynh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Truc Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan Thanh Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan Tri","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu Viet Thi","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram Viet","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trang Xuan","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Viet Nguyen","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"4","key":"3375_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","volume":"35","author":"DSJ Ting","year":"2021","unstructured":"Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS (2021) Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond) 35(4):1084\u20131101","journal-title":"Eye (Lond)"},{"issue":"1","key":"3375_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","volume":"27","author":"M Green","year":"2008","unstructured":"Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27(1):22\u201327","journal-title":"Cornea"},{"issue":"8","key":"3375_CR3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181343","volume":"12","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Naduvilath T, Keay L, Radford C, Dart J, Edwards K et al (2017) Risk factors and causative organisms in microbial keratitis in daily disposable contact lens wear. PLoS ONE 12(8):e0181343","journal-title":"PLoS ONE"},{"key":"3375_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajo.2018.07.040","volume":"195","author":"WB Khor","year":"2018","unstructured":"Khor WB, Prajna VN, Garg P, Mehta JS, Xie L, Liu Z et al (2018) The Asia cornea society infectious keratitis study: a prospective multicenter study of infectious keratitis in Asia. Am J Ophthalmol 195:161\u2013170","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3375_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1167\/iovs.11-7840","volume":"53","author":"A Sy","year":"2012","unstructured":"Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M et al (2012) Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci 53(1):267\u2013272","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3375_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10792-012-9601-x","volume":"32","author":"J Mascarenhas","year":"2012","unstructured":"Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P et al (2012) Differentiation of etiologic agents of bacterial keratitis from presentation characteristics. Int Ophthalmol 32(6):531\u2013538","journal-title":"Int Ophthalmol"},{"issue":"1","key":"3375_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1167\/iovs.14-15241","volume":"56","author":"EP Shen","year":"2014","unstructured":"Shen EP, Hsieh YT, Chu HS, Chang SC, Hu FR (2014) Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis. Invest Ophthalmol Vis Sci 56(1):365\u2013371","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3375_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2021.02.024","volume":"227","author":"R Enzor","year":"2021","unstructured":"Enzor R, Bowers EMR, Perzia B, Perera C, Palazzolo L, Mammen A et al (2021) Comparison of clinical features and treatment outcomes of Pseudomonas aeruginosa keratitis in contact lens and non-contact lens wearers. Am J Ophthalmol 227:1\u201311","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3375_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.33073\/pjm-2020-038","volume":"69","author":"Q Chen","year":"2020","unstructured":"Chen Q, Lu W, Zhou D, Zheng G, Liu H, Qian C et al (2020) Characterization of two macrolide resistance-related genes in multidrug-resistant Pseudomonas aeruginosa Isolates. Pol J Microbiol 69(3):349\u2013356","journal-title":"Pol J Microbiol"},{"key":"3375_CR10","doi-asserted-by":"crossref","unstructured":"Fernandes M, Vira D, Medikonda R, Kumar N (2016) Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 254(2), 315\u201322","DOI":"10.1007\/s00417-015-3208-7"},{"issue":"6","key":"3375_CR11","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001551","volume":"71","author":"A Thacharodi","year":"2022","unstructured":"Thacharodi A, Lamont IL (2022) Aminoglycoside resistance in Pseudomonas aeruginosa: the contribution of the MexXY-OprM efflux pump varies between isolates. J Med Microbiol 71(6):001551","journal-title":"J Med Microbiol"},{"key":"3375_CR12","volume":"76","author":"SMJ Fleiszig","year":"2020","unstructured":"Fleiszig SMJ, Kroken AR, Nieto V, Grosser MR, Wan SJ, Metruccio MME et al (2020) Contact lens-related corneal infection: intrinsic resistance and its compromise. Prog Retin Eye Res 76:100804","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"3375_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSphere.00140-16","volume":"1","author":"JH Hammond","year":"2016","unstructured":"Hammond JH, Hebert WP, Naimie A, Ray K, Van Gelder RD, DiGiandomenico A et al (2016) Environmentally endemic Pseudomonas aeruginosa strains with mutations in LasR are associated with increased disease severity in corneal ulcers. mSphere 1(5):10","journal-title":"mSphere"},{"key":"3375_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2017.07.002","volume":"190","author":"A Kariminik","year":"2017","unstructured":"Kariminik A, Baseri-Salehi M, Kheirkhah B (2017) Pseudomonas aeruginosa quorum sensing modulates immune responses: an updated review article. Immunol Lett 190:1\u20136","journal-title":"Immunol Lett"},{"issue":"3","key":"3375_CR15","first-page":"268","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infection Off Publ Eur Soc Clin Microbiol Infectious Dis 18(3):268\u2013281","journal-title":"Clin Microbiol Infection Off Publ Eur Soc Clin Microbiol Infectious Dis"},{"issue":"1","key":"3375_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12886-018-0882-3","volume":"18","author":"CH Cho","year":"2018","unstructured":"Cho CH, Lee SB (2018) Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study. BMC Ophthalmol 18(1):204","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"3375_CR17","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1167\/iovs.15-17556","volume":"56","author":"N Oka","year":"2015","unstructured":"Oka N, Suzuki T, Ishikawa E, Yamaguchi S, Hayashi N, Gotoh N et al (2015) Relationship of virulence factors and clinical features in keratitis caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 56(11):6892\u20136898","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3375_CR18","unstructured":"Nguyen Thi Truc Mai (2021) Clinical and microbiological characteristics of bacterial corneal ulcers at Ho Chi Minh eye hospital [Thesis for graduation as Ophthalmology residency]: Pham Ngoc Thach medical university"},{"issue":"1","key":"3375_CR19","first-page":"43","volume":"11","author":"B Wang","year":"2018","unstructured":"Wang B, Yang S, Zhai HL, Zhang YY, Cui CX, Wang JY et al (2018) A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients. Int J Ophthalmol 11(1):43\u201347","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"3375_CR20","first-page":"247","volume":"3","author":"RE Hancock","year":"2000","unstructured":"Hancock RE, Speert DP (2000) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist Updates Rev Comment Antimicrobial Anticancer Chemotherapy 3(4):247\u2013255","journal-title":"Drug Resist Updates Rev Comment Antimicrobial Anticancer Chemotherapy"},{"issue":"3","key":"3375_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4065\/mcp.2010.0674","volume":"86","author":"SS Kanj","year":"2011","unstructured":"Kanj SS, Kanafani ZA (2011) Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 86(3):250\u2013259","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"3375_CR22","first-page":"1432","volume":"11","author":"J Zakhour","year":"2022","unstructured":"Zakhour J, Sharara SL, Hindy JR, Haddad SF, Kanj SS (2022) Antimicrobial treatment of Pseudomonas aeruginosa severe sepsis. Antibiotics (Basel, Switzerland). 11(10):1432","journal-title":"Antibiotics (Basel, Switzerland)."},{"issue":"2","key":"3375_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cxo.12621","volume":"101","author":"D Subedi","year":"2018","unstructured":"Subedi D, Vijay AK, Willcox M (2018) Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clin Exp Optom 101(2):162\u2013171","journal-title":"Clin Exp Optom"},{"key":"3375_CR24","first-page":"106","volume":"12","author":"PTP Trang","year":"2015","unstructured":"Trang PTP, Khanh NTK, Tuom TTT (2015) Antibiotic resistance of Staphyloccocus and Pseudomonas aeruginosa in keratitis patients at Ho Chi Minh eye hospital in 2015. Vietnam Med Article 12:106\u2013107","journal-title":"Vietnam Med Article"},{"issue":"5","key":"3375_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaophthalmol.2020.0155","volume":"138","author":"PA Asbell","year":"2020","unstructured":"Asbell PA, Sanfilippo CM, Sahm DF, DeCory HH (2020) Trends in antibiotic resistance among ocular microorganisms in the United States from 2009 to 2018. JAMA Ophthalmol 138(5):439\u2013450","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"3375_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/09286586.2013.790978","volume":"20","author":"CE Oldenburg","year":"2013","unstructured":"Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J et al (2013) Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol 20(3):155\u2013158","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"3375_CR27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcrs.2005.12.108","volume":"32","author":"M Moshirfar","year":"2006","unstructured":"Moshirfar M, Mirzaian G, Feiz V, Kang PC (2006) Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 32(3):515\u2013518","journal-title":"J Cataract Refract Surg"},{"issue":"Suppl 2","key":"3375_CR28","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","volume":"49","author":"JM Blondeau","year":"2004","unstructured":"Blondeau JM (2004) Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol 49(Suppl 2):S73\u2013S78","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 2","key":"3375_CR29","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","volume":"41","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infectious Dis Off Public Infectious Dis Soc Am 41(Suppl 2):S120\u2013S126","journal-title":"Clin Infectious Dis Off Public Infectious Dis Soc Am"},{"issue":"4","key":"3375_CR30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","volume":"133","author":"R Mather","year":"2002","unstructured":"Mather R, Karenchak LM, Romanowski EG, Kowalski RP (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133(4):463\u2013466","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3375_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ICL.0b013e3181e3ef45","volume":"36","author":"HY Hsu","year":"2010","unstructured":"Hsu HY, Nacke R, Song JC, Yoo SH, Alfonso EC, Israel HA (2010) Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Eye Contact Lens 36(4):195\u2013200","journal-title":"Eye Contact Lens"},{"issue":"4","key":"3375_CR32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archophthalmol.2011.45","volume":"129","author":"RE Fintelmann","year":"2011","unstructured":"Fintelmann RE, Hoskins EN, Lietman TM, Keenan JD, Gaynor BD, Cevallos V et al (2011) Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol 129(4):399\u2013402","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"3375_CR33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","volume":"119","author":"E Milder","year":"2012","unstructured":"Milder E, Vander J, Shah C, Garg S (2012) Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 119(7):1420\u20131424","journal-title":"Ophthalmology"},{"issue":"10","key":"3375_CR34","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/AAC.00257-10","volume":"54","author":"C Alvarez-Ortega","year":"2010","unstructured":"Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Mart\u00ednez JL (2010) Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother 54(10):4159\u20134167","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3375_CR35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","volume":"34","author":"DM Livermore","year":"2002","unstructured":"Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infectious Dis Off Public Infectious Dis Soc Am 34(5):634\u2013640","journal-title":"Clin Infectious Dis Off Public Infectious Dis Soc Am"},{"issue":"22","key":"3375_CR36","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2165\/00003495-200363220-00015","volume":"63","author":"SM Cheer","year":"2003","unstructured":"Cheer SM, Waugh J, Noble S (2003) Inhaled tobramycin (TOBI\u00ae). Drugs 63(22):2501\u20132520","journal-title":"Drugs"},{"issue":"4","key":"3375_CR37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/37.4.809","volume":"37","author":"F Bert","year":"1996","unstructured":"Bert F, Lambert-Zechovsky N (1996) Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 37(4):809\u2013813","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3375_CR38","first-page":"980","volume":"9","author":"H Goossens","year":"2003","unstructured":"Goossens H (2003) Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group. Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis 9(9):980\u2013983","journal-title":"Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis"},{"issue":"3","key":"3375_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/jhin.2001.0987","volume":"48","author":"H Hanberger","year":"2001","unstructured":"Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R et al (2001) Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 48(3):161\u2013176","journal-title":"J Hosp Infect"},{"issue":"3","key":"3375_CR40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/09273948.2014.883545","volume":"23","author":"S Gupta","year":"2015","unstructured":"Gupta S, Mittal S, Nayak N, Satpathy G, Khokhar S, Agarwal T (2015) In vitro antibiotic susceptibility of Pseudomonas aeruginosa corneal ulcer isolates. Ocul Immunol Inflamm 23(3):252\u2013255","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"3375_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","volume":"2","author":"A F\u00e0brega","year":"2009","unstructured":"F\u00e0brega A, Madurga S, Giralt E, Vila J (2009) Mechanism of action of and resistance to quinolones. Microb Biotechnol 2(1):40\u201361","journal-title":"Microb Biotechnol"},{"key":"3375_CR42","volume":"85","author":"M Khan","year":"2020","unstructured":"Khan M, Summers S, Rice SA, Stapleton F, Willcox MDP, Subedi D (2020) Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa. Infection Genet Evolution J Molecular Epidemiol Evolut Genet Infectious Dis 85:104574","journal-title":"Infection Genet Evolution J Molecular Epidemiol Evolut Genet Infectious Dis"},{"issue":"9","key":"3375_CR43","first-page":"1271","volume":"11","author":"M L\u00f3pez","year":"2022","unstructured":"L\u00f3pez M, Rojo-Bezares B, Chich\u00f3n G, S\u00e1enz Y (2022) Resistance to fluoroquinolones in pseudomonas aeruginosa from human, animal, food and environmental origin: the role of CrpP and Mobilizable ICEs. Antibiotics (Basel, Switzerland) 11(9):1271","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"4","key":"3375_CR44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43(4):727\u2013737","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"3375_CR45","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1042\/BCJ20220527","volume":"479","author":"DM Foulkes","year":"2022","unstructured":"Foulkes DM, McLean K, Sloniecka M, Rustidge S, Byrne DP, Haneef AS et al (2022) Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity. Biochem J 479(24):2511\u20132527","journal-title":"Biochem J"},{"issue":"1","key":"3375_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","volume":"45","author":"O Lomovskaya","year":"2001","unstructured":"Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M et al (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45(1):105\u2013116","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3375_CR47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000077280","volume":"50","author":"AY Coban","year":"2004","unstructured":"Coban AY, Ekinci B, Durupinar B (2004) A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates. Chemotherapy 50(1):22\u201326","journal-title":"Chemotherapy"},{"issue":"2","key":"3375_CR48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14728214.7.2.223","volume":"7","author":"GW Kaatz","year":"2002","unstructured":"Kaatz GW (2002) Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance. Expert Opin Emerg Drugs 7(2):223\u2013233","journal-title":"Expert Opin Emerg Drugs"},{"issue":"Suppl 1","key":"3375_CR49","first-page":"S15","volume":"5","author":"JC Pech\u00e8re","year":"1999","unstructured":"Pech\u00e8re JC, K\u00f6hler T (1999) Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa. Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis 5(Suppl 1):S15\u2013S18","journal-title":"Clin Microbiol Infection Off Public Eur Soc Clin Microbiol Infectious Dis"},{"issue":"2","key":"3375_CR50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/cid\/ciz816","volume":"71","author":"JM Pogue","year":"2020","unstructured":"Pogue JM, Kaye KS, Veve MP, Patel TS, Gerlach AT, Davis SL et al (2020) Ceftolozane\/tazobactam vs polymyxin or aminoglycoside-based regimens for the treatment of drug-resistant Pseudomonas aeruginosa. Clin Infectious Dis Off Public Infectious Dis Soc Am 71(2):304\u2013310","journal-title":"Clin Infectious Dis Off Public Infectious Dis Soc Am"},{"issue":"9","key":"3375_CR51","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","volume":"70","author":"J Motsch","year":"2020","unstructured":"Motsch J, Murta de Oliveira C, Stus V, K\u00f6ksal I, Lyulko O, Boucher HW et al (2020) RESTORE-IMI 1: A multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections. Clin Infectious Dis Off Public Infectious Dis Soc Am 70(9):1799\u20131808","journal-title":"Clin Infectious Dis Off Public Infectious Dis Soc Am"},{"key":"3375_CR52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jgar.2022.01.023","volume":"28","author":"TA Almangour","year":"2022","unstructured":"Almangour TA, Aljabri A, Al Musawa M, Almohaizeie A, Almuhisen S, Damfu N et al (2022) Ceftolozane-tazobactam vs colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study. J Global Antimicrobial Resist 28:288\u2013294","journal-title":"J Global Antimicrobial Resist"},{"key":"3375_CR53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2147\/IDR.S350976","volume":"15","author":"J Chen","year":"2022","unstructured":"Chen J, Liang Q, Chen X, Wu J, Wu Y, Teng G et al (2022) Ceftazidime\/Avibactam versus polymyxin B in the challenge of carbapenem-resistant Pseudomonas aeruginosa Infection. Infection Drug Resist 15:655\u2013667","journal-title":"Infection Drug Resist"},{"key":"3375_CR54","doi-asserted-by":"crossref","unstructured":"Ryan K. Shields (2023) Emerging \u03b2-lactamases in Pseudomonas aeruginosa that threaten the utility of new \u03b2-lactam\/\u03b2-lactamase inhibitors, 8(5)","DOI":"10.1093\/jacamr\/dlad107"},{"issue":"2","key":"3375_CR55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/42.2.128","volume":"42","author":"P Nordmann","year":"1998","unstructured":"Nordmann P, Guibert M (1998) Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 42(2):128\u2013131","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"3375_CR56","first-page":"772","volume":"13","author":"A Philippon","year":"1984","unstructured":"Philippon A, Thabaut A, Nevot P (1984) Distribution of constituent beta-lactamases in Pseudomonas aeruginosa. Presse Med 13(13):772\u2013776","journal-title":"Presse Med"},{"key":"3375_CR57","unstructured":"Ponniah L (2023) Alternative Treatment Approaches in Bacterial Keratitis"},{"issue":"5","key":"3375_CR58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.11.5.26","volume":"11","author":"JA Mei","year":"2022","unstructured":"Mei JA, Johnson W, Kinn B, Laskey E, Nolin L, Bhamare P et al (2022) Antimicrobial activity of a triple antibiotic combination toward ocular pseudomonas aeruginosa clinical isolates. Trans Vision Sci Technol 11(5):26","journal-title":"Trans Vision Sci Technol"},{"issue":"2","key":"3375_CR59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30(2):557\u2013596","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"3375_CR60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","volume":"104","author":"EA Campbell","year":"2001","unstructured":"Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A et al (2001) Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104(6):901\u2013912","journal-title":"Cell"},{"issue":"5","key":"3375_CR61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","volume":"17","author":"K Bush","year":"2019","unstructured":"Bush K, Bradford PA (2019) Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors. Nat Rev Microbiol 17(5):295\u2013306","journal-title":"Nat Rev Microbiol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03375-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:02:43Z","timestamp":1766167363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03375-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03375-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4918164\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"9"}}